Eli Lilly and Company today announced that preclinical data for agents targeting SMARCA2 (BRM) and multiple KRAS mutations will be presented at the American Association for Cancer Research (AACR) ...

Verastem Oncology , a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, announced today multiple oral and poster presentations at the ...

Fauziya Faruk is the public information officer for the Council of Sacramento Valley Islamic Organizations (COSVIO) and joins us ahead of one of the state’s largest cultural and religious ...

Lake Tahoe is unlike other natural resources when it comes to management and stewardship. The 500-mile watershed spans two states, five counties and a city. More than 50 years ago, Congress ...

Bristol Myers Squibb has reported disappointing results for its checkpoint inhibitor combination Opdualag in melanoma, dashing its hopes of moving the drug earlier in the treatment pathway.

The recently released “2024 Shooting Sports—Retail sales and inventory executive snapshot,” unfortunately, presents a year-over-year 5 to 10 percent decline in firearm unit sales. It does ...

When it comes to books on the firearms used by American military forces of the 20th century, Bruce Canfield is the current dean of authors. With more than a dozen books currently in print, he is ...

Presentations will feature potential best-in-class pan-RAS molecular glue ERAS-0015 and pan-KRAS inhibitor ERAS-4001 Erasca will also present potential first-in-class examples of direct SMP ...

The most common areas for cancer to progress are usually the liver or lungs. Although LDH is not specific to melanoma, it can be a useful test for diagnosing or monitoring skin cancer post-surgical ...

IPC Indice de Precios Y Cotizaciones 53,160.98-316.76-0.59% ...